4Suputtamongkol Y,Intaranongpai S,Smith MD,et al.A double-blind placebo-controlled study of an infusion of lexipafant (platelet-activating factor receptor antagonist) in patients with severe sepsis.Antimicrob Agents Chemother,2000,44 (3):693-696.
5Sun Z,Wang X,Lasson A,et al.Roles of platelet-activating factor,interleukin-l beta and interleukin-6 in intestinal barrier dysfunction induced by mesenteric arterial ischemia and reperfusion.J Surg Res,1999,87 (1):90-100.
6Wang X,Sun Z,Borjesson A,et al.Inhibition of platelet-activating factor,intercellular adhesion molecult 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction.Br J Surg,1999,86 (3):411-416.
7Liu Q,Djuricin G,Rossi H,et al.The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats.Am Surg,1999,65 (7):611-616.
8Schwarz T.Lexipafant:a glimmer of hope for pancreatitis.International Pharma,1995,10 (7):3-6.
9Abu Zidan FM.Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock.Surgery,1998,123 (2):248-249.
10Schifitto G,Sacktor N,Marder K,et al.Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment neurological AIDS research consortium.Neurology,1999,53 (2):391-396.
